GATA3 and endometrial carcinoma: They found that GATA3 has a sensitivity of 98% and a specificity of 98% to differentiate mesonephric lesions to endocervical and endometrial carcinomas [20], which was confirmed by the whole proteome analysis by Gibbard et al. [5].